Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-059807
Filing Date
2022-03-01
Accepted
2022-03-01 07:21:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 POS AM d145090dposam.htm POS AM 392452
2 EX-5.1 d145090dex51.htm EX-5.1 41856
3 EX-23.1 d145090dex231.htm EX-23.1 1680
4 GRAPHIC g145090dsp3.jpg GRAPHIC 2317
5 GRAPHIC g145090g04s10.jpg GRAPHIC 37679
6 GRAPHIC g145090g51k56.jpg GRAPHIC 38993
  Complete submission text file 0001193125-22-059807.txt   538568
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-257684 | Film No.: 22693937
SIC: 2834 Pharmaceutical Preparations